Amgen (AMGN) Shares Outstanding (Diluted Average) (2009 - 2026)

Amgen's Shares Outstanding (Diluted Average) history runs 18 years deep, the most recent figure standing at $544.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 0.55% year-over-year to $544.0 million; the TTM figure through Mar 2026 stood at $544.0 million (up 0.55% YoY), while the FY2025 annual figure was $542.0 million, changed 0.18% from the prior year.
• Shares Outstanding (Diluted Average) was $544.0 million for Q1 2026 at Amgen, roughly flat from $542.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $551.0 million in Q1 2022 to a low of $536.0 million in Q1 2024.
• Historically, Shares Outstanding (Diluted Average) has averaged $541.1 million across 5 years, with a median of $541.0 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) dropped 5.88% in 2022, then climbed 0.93% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $541.0 million in 2022, then retreated by 0.55% to $538.0 million in 2023, then gained by 0.56% to $541.0 million in 2024, then gained by 0.18% to $542.0 million in 2025, then advanced by 0.37% to $544.0 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $544.0 million (Q1 2026), $542.0 million (Q4 2025), and $542.0 million (Q3 2025), per Business Quant data.